Cellectis S.A. (CLLS) Return on equity 2016–2025
Cellectis S.A. (CLLS) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-89.1%FY2025 · since FY2016: -24.7% → -89.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -89.1% | -61.0 pp |
| FY2024 | -28.1% | +91.3 pp |
| FY2023 | -119.3% | -29.3 pp |
| FY2022 | -90.0% | -38.4 pp |
| FY2021 | -51.6% | -23.0 pp |
| FY2020 | -28.6% | +3.8 pp |
| FY2019 | -32.4% | -13.2 pp |
| FY2018 | -19.2% | +18.3 pp |
| FY2017 | -37.5% | -12.9 pp |
| FY2016 | -24.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice